Is NDRA or NRXS more undervalued in 2026?

CirclFi compares ENDRA Life Sciences Inc. (NDRA) and Neuraxis, Inc. (NRXS) using 13 institutional-grade valuation models. NDRA has a Quality of Company score of 3.6/10 while NRXS scores 6.9/10.

Which is a better buy — NDRA or NRXS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NDRA and NRXS valuations compare?

NDRA at $5.50 and NRXS at $7.41 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NDRA vs NRXS Valuation Comparison 2026 — Intrinsic Value Analysis

NDRA

Electromedical & Electrotherapeutic Apparatus

ENDRA Life Sciences Inc.

Quality

3.6

out of 10

Value Trap

LOW

Price

$5.50

Last close

Models

6/13

Active

NRXS

Electromedical & Electrotherapeutic Apparatus

Neuraxis, Inc.

Quality

6.9

out of 10

Value Trap

SAFE

Price

$7.41

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	NDRA Fair Value	NDRA Upside	NRXS Fair Value	NRXS Upside
Bayesian DCF	Intrinsic	$1.47	-73.4%	$2.02	-72.7%
Earnings Power Value	Intrinsic	—	—	$1.57	-80.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$9.64	+75.3%	$0.86	-88.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NDRA vs NRXS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NDRA vs NRXS — Which Stock Is More Undervalued?

NRXS scores higher with a 6.9/10 quality rating vs NDRA's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ENDRA Life Sciences Inc. (NDRA) and Neuraxis, Inc. (NRXS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NDRA currently trades at $5.50 with a QOC of 3.6/10, while NRXS trades at $7.41 with a QOC of 6.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).